PBSV — Pharma-Bio Serv Balance Sheet
0.000.00%
- $14.04m
 - $3.31m
 - $9.51m
 
- 85
 - 59
 - 30
 - 60
 
Annual balance sheet for Pharma-Bio Serv, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st  | C2021 October 31st  | 2022 October 31st  | 2023 October 31st  | 2024 October 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17.1 | 17.5 | 14.5 | 15 | 12.7 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11 | 4.61 | 4.98 | 3.94 | 2.51 | 
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 28.6 | 22.8 | 19.9 | 19.4 | 15.7 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.06 | 0.745 | 0.576 | 0.389 | 0.368 | 
| Other Long Term Assets | |||||
| Total Assets | 29.9 | 23.9 | 20.7 | 19.9 | 16.3 | 
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.79 | 2.67 | 2.11 | 2.15 | 1.89 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 7.2 | 5.01 | 4.09 | 3.78 | 2.58 | 
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 22.7 | 18.9 | 16.6 | 16.1 | 13.7 | 
| Total Liabilities & Shareholders' Equity | 29.9 | 23.9 | 20.7 | 19.9 | 16.3 | 
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |